SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-024289
Filing Date
2021-05-03
Accepted
2021-05-03 17:28:44
Documents
3
Period of Report
2021-05-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140301-8k_aditxthera.htm 8-K 17150
2 PRESS RELEASE ea140301ex99-1_aditxthera.htm EX-99.1 11125
3 GRAPHIC image_001.jpg GRAPHIC 3423
  Complete submission text file 0001213900-21-024289.txt   34332
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 21884840
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences